Tumor-induced Thymic Involution Via Inhibition of IL-7R Alpha and Its JAK-STAT Signaling Pathway: Protection by Black Tea
Overview
Pharmacology
Authors
Affiliations
Down-regulation of cell-mediated immune functions occurring at late stages of cancer may be related to the thymic involution since thymus is the major site of T cell maturation, proliferation, and differentiation. We found that in Ehrlich's ascites carcinoma (EAC)-bearing mice there was profound depletion of CD4+ and CD8+ cells in peripheral blood with severely damaged thymus on 21st day of tumor inoculation. However, treatment with black tea at an antitumor dose of 2.5% significantly reduced such depletion and protected the thymus considerably from tumor onslaught. A search for the underlying mechanism revealed EAC-induced IL-7Ralpha down-regulation, inhibition of JAK3 and STAT5 phosphorylation, and decrease in Bcl-2/Bax ratio in thymocytes that finally led to thymocyte apoptosis in one hand and T cell maturation block on the other. Interestingly, black tea treatment prevented IL-7Ralpha down-regulation and protected the signaling cascade through JAK-STAT thereby inhibiting tumor-induced thymic apoptosis and ensuring proper functioning of this organ in tumor-bearing host.
Features and applications of Ehrlich tumor model in cancer studies: a literature review.
Radulski D, Stipp M, Galindo C, Acco A Transl Breast Cancer Res. 2024; 4:22.
PMID: 38751464 PMC: 11093101. DOI: 10.21037/tbcr-23-32.
Li D, Cao D, Sun Y, Cui Y, Zhang Y, Jiang J Front Immunol. 2024; 15:1331641.
PMID: 38348027 PMC: 10859531. DOI: 10.3389/fimmu.2024.1331641.
Interleukin (IL)-7 Signaling in the Tumor Microenvironment.
Bednarz-Misa I, Bromke M, Krzystek-Korpacka M Adv Exp Med Biol. 2021; 1290:9-49.
PMID: 33559853 DOI: 10.1007/978-3-030-55617-4_2.
A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma.
Sun S, Ji H, Feng Y, Kang Y, Yu J, Liu A Cancer Manag Res. 2018; 10:417-424.
PMID: 29551914 PMC: 5842769. DOI: 10.2147/CMAR.S157512.
Saha S, Sakib Hossain D, Mukherjee S, Mohanty S, Mazumdar M, Mukherjee S BMC Complement Altern Med. 2013; 13:230.
PMID: 24053127 PMC: 3856502. DOI: 10.1186/1472-6882-13-230.